Literature DB >> 1467379

The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study.

A L Stoll1, P F Renshaw, G S Sachs, A R Guimaraes, C Miller, B M Cohen, B Lafer, R G Gonzalez.   

Abstract

Lithium specifically and potentially inhibits membrane transport of choline. However, the effect of lithium on human neuronal choline content is unknown. This study was performed to determine if lithium alters the human brain choline concentration in vivo. In vivo proton magnetic resonance spectroscopy was used to compare the relative brain concentration of choline-containing compounds in seven lithium-treated patients and six lithium-free controls. No significant difference was observed in the mean relative choline resonance between the patient and control groups. Lithium treatment did not appear to alter the overall brain content of choline-containing compounds. It remains possible that a component of these compounds, particularly free choline, is elevated during lithium treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1467379     DOI: 10.1016/0006-3223(92)90184-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

1.  Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy.

Authors:  P H Silverstone; C C Hanstock; S Rotzinger
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

2.  Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder.

Authors:  T Kato; H Hamakawa; T Shioiri; J Murashita; Y Takahashi; S Takahashi; T Inubushi
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

3.  Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.

Authors:  Brent P Forester; Chelsea T Finn; Yosef A Berlow; Megan Wardrop; Perry F Renshaw; Constance M Moore
Journal:  Bipolar Disord       Date:  2008-09       Impact factor: 6.744

4.  The effects of lithium chloride and other substances on levels of brain N-acetyl-L-aspartic acid in Canavan disease-like rats.

Authors:  Morris H Baslow; Kazuhiro Kitada; Raymond F Suckow; Basalingappa L Hungund; Tadao Serikawa
Journal:  Neurochem Res       Date:  2002-05       Impact factor: 3.996

Review 5.  Neurochemical predictors of response to pharmacologic treatments for bipolar disorder.

Authors:  Melissa P Delbello; Stephen M Strakowski
Journal:  Curr Psychiatry Rep       Date:  2004-12       Impact factor: 8.081

6.  Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate.

Authors:  Ren H Wu; Tina O'Donnell; Michele Ulrich; Sheila J Asghar; Christopher C Hanstock; Peter H Silverstone
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-07-30

7.  Neurochemical metabolites in the medial prefrontal cortex in bipolar disorder: A proton magnetic resonance spectroscopy study.

Authors:  Osman Ozdel; Demet Kalayci; Gülfizar Sözeri-Varma; Yilmaz Kiroğlu; Selim Tümkaya; Tugçe Toker-Uğurlu
Journal:  Neural Regen Res       Date:  2012-12-25       Impact factor: 5.135

Review 8.  Glutamatergic and N-Acetylaspartate Metabolites in Bipolar Disorder: A Systematic Review and Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies.

Authors:  Jonathan Chabert; Etienne Allauze; Bruno Pereira; Carine Chassain; Ingrid De Chazeron; Jean-Yves Rotgé; Philippe Fossati; Pierre-Michel Llorca; Ludovic Samalin
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.